| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |